- Home
- GSL vs OLMA Comparison
GSL vs OLMA Comparison
Compare GSL & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSL | OLMA |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | Greece | United States |
| Employees | 7 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GSL | OLMA |
|---|---|---|
| Price | $38.34 | $15.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $43.50 | ★ $44.89 |
| AVG Volume (30 Days) | 232.1K | ★ 841.7K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.05 | $3.89 |
| 52 Week High | $41.40 | $36.26 |
Technical Indicators
Market Signals| Indicator | GSL | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 41.85 |
| Support Level | $36.82 | $13.11 |
| Resistance Level | $38.52 | $16.99 |
| Average True Range (ATR) | 0.93 | 0.85 |
| MACD | -0.05 | 0.18 |
| Stochastic Oscillator | 41.28 | 22.79 |
Price Performance
Historical ComparisonAbout GSL Global Ship Lease Inc New
Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.